Cargando…

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening

The aim of this study is to determine the survival of patients with breast cancer treated with adjuvant chemotherapy (ACh) after the diagnosis by screening, taking comorbidity into account. This multicenter cohort study examined a population of patients taking part in four national screening program...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zarcos‐Pedrinaci, Irene, Redondo, Maximino, Louro, Javier, Rivas‐Ruiz, Francisco, Téllez, Teresa, Pérez, Diego, Medina Cano, Francisco, Machan, Kenza, Domingo, Laia, Mar Vernet, Maria, Padilla‐Ruiz, Maria, Castells, Xavier, Rueda, Antonio, Sala, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825992/ https://www.ncbi.nlm.nih.gov/pubmed/31549794 http://dx.doi.org/10.1002/cam4.2488

Ejemplares similares

Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer
por: Zarcos-Pedrinaci, Irene, et al.
Publicado: (2018)

Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer
por: Padilla-Ruiz, María, et al.
Publicado: (2022)

Factors that influence treatment delay in patients with colorectal cancer
por: Zarcos-Pedrinaci, Irene, et al.
Publicado: (2016)

Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients
por: Politi, Julieta, et al.
Publicado: (2020)

Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort
por: Santiá, Paula, et al.
Publicado: (2022)

Detection methods predict differences in biology and survival in breast cancer patients
por: Redondo, Maximino, et al.
Publicado: (2012)

Personalized breast cancer screening strategies: A systematic review and quality assessment
por: Román, Marta, et al.
Publicado: (2019)

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case–control study
por: Posso, Margarita, et al.
Publicado: (2017)

A systematic review and quality assessment of individualised breast cancer risk prediction models
por: Louro, Javier, et al.
Publicado: (2019)

Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
por: Rueda, Antonio, et al.
Publicado: (2012)

High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer
por: Maañón, José, et al.
Publicado: (2018)

Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study
por: Jansana, Anna, et al.
Publicado: (2020)

Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study
por: Miret, Carme, et al.
Publicado: (2019)

Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening
por: Louro, Javier, et al.
Publicado: (2021)

Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report
por: Pedrinaci, Irene Zarcos, et al.
Publicado: (2012)

Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes
por: Domingo, Laia, et al.
Publicado: (2019)

A qualitative exploration of patient safety in a hospital setting in Spain: Policy and practice recommendations on patients' and companions' participation
por: Abiétar, Daniel G., et al.
Publicado: (2023)

Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization
por: Sala, Maria, et al.
Publicado: (2014)

Impact of COVID-19 on Hospital Admissions and Healthcare Quality Indicators in Non-COVID Patients: A Retrospective Study of the First COVID-19 Year in a University Hospital in Spain
por: Domingo, Laia, et al.
Publicado: (2022)

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
por: Blancas, I., et al.
Publicado: (2021)

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program
por: Castells, Xavier, et al.
Publicado: (2014)

Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain
por: Domingo, Laia, et al.
Publicado: (2015)

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
por: Vilaprinyo, Ester, et al.
Publicado: (2014)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Health services research in patients with breast cancer (CAMISS-prospective): study protocol for an observational prospective study
por: García-Gutierrez, Susana, et al.
Publicado: (2018)

Clinical Significance of Langerhans Cells in Squamous Cell Carcinoma of the Larynx
por: Esteban, Francisco, et al.
Publicado: (2012)

The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Liu, Jingjing, et al.
Publicado: (2019)

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
por: Miret, Carme, et al.
Publicado: (2023)

Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study
por: Martín-Bravo, Celia, et al.
Publicado: (2021)

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2018)

Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility
por: Arnau-Collell, Coral, et al.
Publicado: (2020)

Pre-analytical errors management in the clinical laboratory: a five-year study
por: Giménez-Marín, Angeles, et al.
Publicado: (2014)

The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
por: Dibajnia, Pooya, et al.
Publicado: (2023)

Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
por: Cuadros, Marta, et al.
Publicado: (2022)

The role and prognostic value of apoptosis in colorectal carcinoma
por: Alcaide, Julia, et al.
Publicado: (2013)

Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the Future
por: Sargent, Daniel, et al.
Publicado: (2010)

Microstructural and Thermo-Physical Characterization of a Water Hyacinth Petiole for Thermal Insulation Particle Board Manufacture
por: Salas-Ruiz, Adela, et al.
Publicado: (2019)

Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
por: García-Aranda, Marilina, et al.
Publicado: (2022)

Calcium Homeostasis in the Development of Resistant Breast Tumors
por: Martin-García, Desirée, et al.
Publicado: (2023)

Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_65122ceq83dt1belcb06gv8jbi